Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Miniaturized screening technologies for drug discovery.

J M Cooper1, A E G Cass

  • 1Department of Electronics, University of Glasgow, Glasgow G12 8LT, Scotland, UK. jmcooper@elec.gla.ac.uk

Biochemical Society Transactions
|August 28, 2002
PubMed
Summary

Adaptive Profiling (APL) uses microsystems technology for pharmaceutical R&D. Their tools aid early drug candidate identification, targeting the biological screening and toxicity assessment market.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Creating tissue on chip constructs in microtitre plates for drug discovery.

RSC advances·2022
Same author

Electric Single-Molecule Hybridization Detector for Short DNA Fragments.

Analytical chemistry·2018
Same author

Delivering precision antimicrobial therapy through closed-loop control systems.

The Journal of antimicrobial chemotherapy·2017
Same author

Desvenlafaxine overdose and the occurrence of serotonin toxicity, seizures and cardiovascular effects.

Clinical toxicology (Philadelphia, Pa.)·2016
Same author

Corrigendum: Visualization of Surface Acoustic Waves in Thin Liquid Films.

Scientific reports·2016
Same author

Visualization of Surface Acoustic Waves in Thin Liquid Films.

Scientific reports·2016

Area of Science:

  • Biotechnology and Pharmaceutical Sciences
  • Microsystems Engineering
  • Molecular Biology

Background:

  • The pharmaceutical industry requires advanced tools for drug discovery.
  • Current markets for biological screening, bioavailability, and toxicity assessment are valued at $10 billion.
  • Microsystems technology offers potential for enhanced R&D processes.

Purpose of the Study:

  • To introduce Adaptive Profiling (APL) as a service and technology provider in pharmaceutical R&D.
  • To highlight APL's role in accelerating the identification of qualified drug candidates.
  • To position APL to capture a significant market share in biological screening and assessment.

Main Methods:

  • Leveraging microsystems technology.
  • Integrating advances in chemistry and molecular biology.

Related Experiment Videos

  • Developing decision-making tools for drug development.

    • Main Results:

    • APL aims to provide unique decision-making tools.
    • These tools facilitate earlier identification of drug candidates.
    • The company is positioned to address a large market.

    Conclusions:

    • Adaptive Profiling (APL) offers innovative solutions for pharmaceutical R&D.
    • The company's technology can significantly impact drug discovery timelines.
    • APL is poised for substantial growth within the biological screening and toxicity assessment market.